Stocks and Investing
Stocks and Investing
Mon, September 30, 2024
[ Mon, Sep 30th 2024
] - WOPRAI
[ Mon, Sep 30th 2024
] - WOPRAI
[ Mon, Sep 30th 2024
] - WOPRAI
[ Mon, Sep 30th 2024
] - WOPRAI
[ Mon, Sep 30th 2024
] - WOPRAI
[ Mon, Sep 30th 2024
] - WOPRAI
[ Mon, Sep 30th 2024
] - WOPRAI
[ Mon, Sep 30th 2024
] - WOPRAI
Fri, September 27, 2024
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
[ Fri, Sep 27th 2024
] - WOPRAI
Gary Nachman Initiated (ACHV) at Strong Buy and Held Target at $20 on, Sep 27th, 2024
Gary Nachman of Raymond James, Initiated "Achieve Life Sciences, Inc." (ACHV) at Strong Buy and Held Target at $20 on, Sep 27th, 2024.
Gary has made no other calls on ACHV in the last 4 months.
There is 1 other peer that has a rating on ACHV. Out of the 1 peers that are also analyzing ACHV, 0 agree with Gary's Rating of Hold.
This is the rating of the analyst that currently disagrees with Gary
- Francois Brisebois of "Oppenheimer" Reiterated at Buy and Held Target at $11 on, Thursday, August 15th, 2024
Contributing Sources